Physician profile
Katarina Stopko
NPI 1639361710
$617.51
in general payments reported to CMS, 2019-2025
10 companies · $119 in 2025
The $119 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $338 · 2020: $33.42 · 2022: $17.72 · 2023: $39.56 · 2024: $69.98 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $228.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $228.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $174.75 | 2019 | |
| Merck Sharp & Dohme LLC | $90.90 | 2019-2025 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Cranial Technologies, INC | $78.57 | 2020-2025 | Doc Band |
| Ironshore Pharmaceuticals INC. | $61.44 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $57.05 | 2024-2025 | Qelbree |
| Sobi, INC | $45.62 | 2019 | |
| Glaxosmithkline, LLC. | $41.07 | 2019-2025 | Bexsero |
| Neos Therapeutics, LP | $31.14 | 2019 | |
| Shire North American Group INC | $19.29 | 2019 | |
| Collegium Pharmaceutical, INC. | $17.68 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katarina Stopko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.